EXEMESTANE
Generic: EXEMESTANE
Zydus Pharmaceuticals USA Inc.Manufacturer
ORALRoute
EXEMESTANEActive Substance
2018-10-03Original Approval
EXEMESTANE is FDA application ANDA202602, sponsored by ZYDUS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
1,477 reports
2
MALIGNANT NEOPLASM PROGRESSION
1,406 reports
3
DIARRHOEA
1,221 reports
4
NAUSEA
1,197 reports
5
DYSPNOEA
960 reports
6
ARTHRALGIA
935 reports
7
COUGH
738 reports
8
ASTHENIA
731 reports
9
HEADACHE
716 reports
10
VOMITING
698 reports